Ronald Plott, MD
Dermatology · Fort Worth, TXNPI 1558569087
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Sun Pharmaceutical Industries Inc. accounts for 62.3% of it on its own, with 45 other manufacturers making up the rest. Reporting peaked in 2022 at $63,106 and has fallen 85.1% since, to $9,419 in 2025. Among dermatology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 854 payments — averaging $203.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$109K
- Galderma Laboratories, L.p.$24K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$13K
- Journey Medical Corporation$6K
- UCB, Inc.$5K
- EPI Health, LLC$4K
- plus $14K from 40 others
Across 112 payments — averaging $15,646 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$1.2M
- Amgen$443K
- AbbVie$52K
- Incyte Corporation$33K
- Pfizer$18K
What the payments were for
- Consulting fees$36,05021%
- Speaking & faculty fees$102,74259%
- Travel & lodging$13,2568%
- Food & beverage$21,83413%
- Education$3240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Winlevi$88,870
- ODOMZO$11,790
- DUOBRII$11,178
- ABSORICA LD$10,957
- Cloderm$4,420
- Rhofade$4,420
- ABSORICA$4,400
- Sitavig$3,882
- Minolira 105mg$3,882
- Minolira 135mg$3,882
- Bimzelx$1,673
- MINOLIRA EXTENDED RELEASE$1,076
- SILIQ$672
- Exelderm$633
- Targadox$633
- JUBLIA$625
- ALTRENO$559
- WYNZORA$538
- BRYHALI$437
- OPZELURA$370
How this compares
$174,205 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $142,867 |
| Fluocinolone Acetonide | 126 | $5,778 |
| Triamcinolone Acetonide | 255 | $4,263 |
| Calcipotriene | 28 | $2,421 |
| Fluorouracil | 39 | $2,346 |
| CiclopiroxCiclopirox Olamine | 101 | $2,322 |
| ValacyclovirValacyclovir Hcl | 47 | $1,943 |
| Minocycline Hcl | 76 | $1,639 |
| Clobetasol Propionate | 51 | $1,338 |
| Metronidazole | 33 | $1,295 |
| Tretinoin | 16 | $1,275 |
| Desoximetasone | 18 | $878 |
| Cephalexin | 26 | $541 |
| Clindamycin Phosphate | 13 | $531 |
| Hydroxychloroquine Sulfate | 23 | $445 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fort Worth
- Patrick KeehanFort Worth$713K
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
- Ross RaduskyDallas$1.2M
- Joseph MerolaDallas$1.2M
- Daniel CarrascoAustin$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.